GCAC
TMO icon

Guardian Capital Advisors (Canada)’s Thermo Fisher Scientific TMO Stock Holding History

Guardian Capital Advisors (Canada)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-789
Closed -$389K – 176
2023
Q3 		$389K Sell
789
-313
-28% -$167K 0.04% 136
2023
Q2 		$580K Buy
+1,102
New +$595K 0.07% 113

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Guardian Capital Advisors (Canada)'s TMO Position: Q4 2023 in Review

Guardian Capital Advisors (Canada) sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 789 shares — an estimated $389K sold.

Guardian Capital Advisors (Canada) first reported a position in TMO in Q2 2023 and held it in 2 quarters. The position peaked at $580K in Q2 2023. 2,490 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

  • Guardian Capital Advisors (Canada) reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
  • Guardian Capital Advisors (Canada) sold 789 Thermo Fisher Scientific shares in Q4 2023, an estimated $389K.
  • Guardian Capital Advisors (Canada) first reported a position in Thermo Fisher Scientific in Q2 2023 and held it in 2 quarters.
  • Guardian Capital Advisors (Canada)'s Thermo Fisher Scientific position peaked at $580K in Q2 2023.
  • 2,490 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Guardian Capital Advisors (Canada)'s 13F filing for Q4 2023, filed 8 Feb 2024.